World’s First Human Implant of a 3D-Printed Cornea Restores Sight
December 15, 2025
Background
Temporomandibular Disorders (TMD) refer to conditions that affect the temporomandibular joint (TMJ), which connects the jawbone to the skull. TMD encompasses a range of disorders that cause pain and dysfunction in the joint of the jaw and the muscles that control jaw movement. It is estimated that around 5-12% of the population experiences TMD symptoms at some point, with a higher prevalence among women.Â
Epidemiology
Temporomandibular Disorders (TMD) epidemiology provides insights into this condition’s prevalence, incidence, and distribution within populations. However, it’s important to note that epidemiological data on TMD can vary due to differences in study methodologies, diagnostic criteria, and population characteristics. Here is an overview of the epidemiological aspects of TMD:Â
The prevalence of TMD varies widely across different studies and populations. Estimates suggest that approximately 5-12% of the general population experiences TMD symptoms at some point. Women are more commonly affected by TMD, with a female-to-male ratio of around 2:1 to 9:1, depending on the study population.Â
Anatomy
Pathophysiology
Temporomandibular Disorders (TMD) pathophysiology involves complex interactions between various factors, including the temporomandibular joint (TMJ), associated muscles, nerves, and surrounding structures.Â
Etiology
The etiology, or underlying causes, of Temporomandibular Disorders (TMD), is likely to arise from genetic, anatomical, biomechanical, behavioral, and environmental factors. While the exact cause can vary from person to person, the following are some commonly recognized etiological factors associated with TMD:Â
Genetics
Prognostic Factors
Prognostic factors in Temporomandibular Disorders (TMD) refer to the factors that can influence the course, outcome, and response to treatment for individuals with TMD. Understanding these prognostic factors can help clinicians predict the likely outcome of TMD and tailor treatment plans accordingly. While individual responses can vary, here are some commonly recognized prognostic factors in TMD:Â
Clinical History
Non-specific signs & symptomsÂ
   Systemic signs & symptomsÂ
Age Group:Â Â
Physical Examination
Age group
Associated comorbidity
Associated activity
Acuity of presentation
Acute TMD is the sudden onset of symptoms after a specific event or trigger. For example, acute TMD may result from trauma to the jaw, such as a direct blow or whiplash injury. Acute presentations may involve severe pain, limited jaw movement, muscle spasms, and swelling in the jaw joint area.
Subacute TMD refers to symptoms that have been present for a relatively short duration, typically between acute and chronic presentations. The symptoms may have developed over days to weeks, including jaw pain, muscle stiffness, clicking or popping sounds, and mild limitations in jaw movement.
Differential Diagnoses
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
Temporomandibular Disorders (TMD) treatment aims to alleviate pain, improve jaw function, and enhance the overall quality of life. The specific treatment approach for TMD can vary depending on the individual’s symptoms, underlying causes, and the severity of the condition. It often involves a combination of conservative, non-invasive measures.Â
by Stage
by Modality
Chemotherapy
Radiation Therapy
Surgical Interventions
Hormone Therapy
Immunotherapy
Hyperthermia
Photodynamic Therapy
Stem Cell Transplant
Targeted Therapy
Palliative Care
modification-of-environment
Modifying the environment can be a supportive strategy in treating temporomandibular disorders (TMD). By making certain adjustments, individuals with TMD can create a more favorable environment for their jaw and reduce potential triggers for pain and discomfort. Here are some modifications that can be helpful:Â
patient-education-self-care
Patient education and self-care strategies can significantly contribute to TMD management. By empowering patients to take an active role in their care and providing them with the necessary tools and knowledge, they can better understand their condition, manage symptoms, and improve their quality of life.Â
Utilization of TMD for NSAIDs
Nonsteroidal anti-inflammatory drugs (NSAIDs) manage pain and inflammation associated with temporomandibular disorders (TMD) in adults. NSAIDs reduce the production of prostaglandins, which are responsible for pain and inflammation.Â
Diclofenac is an NSAID commonly used to relieve pain and reduce inflammation in various conditions, including temporomandibular disorders (TMD). TMD refers to conditions that affect the temporomandibular joint (TMJ) and the muscles surrounding it, leading to jaw pain, difficulty in jaw movement, and other associated symptoms.Â
Acetaminophen, or paracetamol, is an over-the-counter pain reliever used to manage pain associated with temporomandibular disorders (TMD). TMD refers to conditions affecting the temporomandibular joint (TMJ) and the surrounding muscles, causing pain, jaw dysfunction, and other related symptoms.Â
Acetaminophen works by blocking pain signals in the brain and reducing fever. It is not classified as a nonsteroidal anti-inflammatory drug (NSAID) like ibuprofen or diclofenac, as it does not have significant anti-inflammatory effects.Â
Skeletal Muscle Relaxants
Skeletal muscle relaxants are a class of medications that may be prescribed to manage the symptoms of temporomandibular disorders (TMD). These medications target the muscles involved in jaw movement, helping to reduce muscle tension, spasm, and associated pain.Â
5-10 mg orally once at nightÂ
Cyclobenzaprine is a muscle relaxant sometimes prescribed to manage muscle-related pain and muscle spasms associated with temporomandibular disorders (TMD).Â
Cyclobenzaprine acts on the central nervous system to help relax muscles and relieve muscle spasms. It increases the brain’s and spinal cord’s inhibitory signals, thereby reducing muscle contractions and promoting muscle relaxation.Â
400-800 mg orally three times daily.
Metaxalone is a muscle relaxant sometimes prescribed to manage muscle-related pain and muscle spasms associated with temporomandibular disorders (TMD).Â
Metaxalone acts on the central nervous system to help relax muscles and relieve muscle spasms. It works by inhibiting nerve impulses or altering the perception of pain signals in the brain and spinal cord.Â
Tricyclic antidepressantsÂ
Tricyclic antidepressants (TCAs) are a class of medications primarily used to treat depression. However, they can also be prescribed for other conditions, including some types of chronic pain, such as temporomandibular disorders (TMD). TMD refers to conditions affecting the jaw joint and surrounding muscles, causing pain and dysfunction.Â
Nortriptyline is a tricyclic antidepressant sometimes prescribed off-label to manage chronic pain, including pain associated with temporomandibular disorders (TMD). TMD refers to conditions affecting the temporomandibular joint (TMJ) and the surrounding muscles, leading to jaw pain, limited jaw movement, and other related symptoms.Â
Amitriptyline is a tricyclic antidepressant sometimes prescribed off-label to manage chronic pain, including pain associated with temporomandibular disorders (TMD). TMD refers to conditions affecting the temporomandibular joint (TMJ) and the muscles surrounding it, causing jaw pain, limited jaw movement, and other related symptoms.Â
Â
intervention-with-a-procedure
When conservative treatments such as medication, physical therapy, and lifestyle modifications do not provide sufficient relief for temporomandibular disorders (TMD), intervention with a procedure may be considered.
The choice of procedure depends on the specific TMD diagnosis, severity of symptoms, and individual patient factors. Here are a few examples of procedures that may be used for TMD:Â
the-phase-of-management
Managing temporomandibular disorders typically involves several phases, each with specific goals and interventions. They include:Â
Medication
Future Trends
References
Temporomandibular Disorder in AdultsÂ
https://www.ncbi.nlm.nih.gov/books/NBK551612/Â
Â
Â
Â
Temporomandibular Disorders (TMD) refer to conditions that affect the temporomandibular joint (TMJ), which connects the jawbone to the skull. TMD encompasses a range of disorders that cause pain and dysfunction in the joint of the jaw and the muscles that control jaw movement. It is estimated that around 5-12% of the population experiences TMD symptoms at some point, with a higher prevalence among women.Â
Temporomandibular Disorders (TMD) epidemiology provides insights into this condition’s prevalence, incidence, and distribution within populations. However, it’s important to note that epidemiological data on TMD can vary due to differences in study methodologies, diagnostic criteria, and population characteristics. Here is an overview of the epidemiological aspects of TMD:Â
The prevalence of TMD varies widely across different studies and populations. Estimates suggest that approximately 5-12% of the general population experiences TMD symptoms at some point. Women are more commonly affected by TMD, with a female-to-male ratio of around 2:1 to 9:1, depending on the study population.Â
Temporomandibular Disorders (TMD) pathophysiology involves complex interactions between various factors, including the temporomandibular joint (TMJ), associated muscles, nerves, and surrounding structures.Â
The etiology, or underlying causes, of Temporomandibular Disorders (TMD), is likely to arise from genetic, anatomical, biomechanical, behavioral, and environmental factors. While the exact cause can vary from person to person, the following are some commonly recognized etiological factors associated with TMD:Â
Prognostic factors in Temporomandibular Disorders (TMD) refer to the factors that can influence the course, outcome, and response to treatment for individuals with TMD. Understanding these prognostic factors can help clinicians predict the likely outcome of TMD and tailor treatment plans accordingly. While individual responses can vary, here are some commonly recognized prognostic factors in TMD:Â
Non-specific signs & symptomsÂ
   Systemic signs & symptomsÂ
Age Group:Â Â
Acute TMD is the sudden onset of symptoms after a specific event or trigger. For example, acute TMD may result from trauma to the jaw, such as a direct blow or whiplash injury. Acute presentations may involve severe pain, limited jaw movement, muscle spasms, and swelling in the jaw joint area.
Subacute TMD refers to symptoms that have been present for a relatively short duration, typically between acute and chronic presentations. The symptoms may have developed over days to weeks, including jaw pain, muscle stiffness, clicking or popping sounds, and mild limitations in jaw movement.
Temporomandibular Disorders (TMD) treatment aims to alleviate pain, improve jaw function, and enhance the overall quality of life. The specific treatment approach for TMD can vary depending on the individual’s symptoms, underlying causes, and the severity of the condition. It often involves a combination of conservative, non-invasive measures.Â
Modifying the environment can be a supportive strategy in treating temporomandibular disorders (TMD). By making certain adjustments, individuals with TMD can create a more favorable environment for their jaw and reduce potential triggers for pain and discomfort. Here are some modifications that can be helpful:Â
Patient education and self-care strategies can significantly contribute to TMD management. By empowering patients to take an active role in their care and providing them with the necessary tools and knowledge, they can better understand their condition, manage symptoms, and improve their quality of life.Â
Nonsteroidal anti-inflammatory drugs (NSAIDs) manage pain and inflammation associated with temporomandibular disorders (TMD) in adults. NSAIDs reduce the production of prostaglandins, which are responsible for pain and inflammation.Â
Diclofenac is an NSAID commonly used to relieve pain and reduce inflammation in various conditions, including temporomandibular disorders (TMD). TMD refers to conditions that affect the temporomandibular joint (TMJ) and the muscles surrounding it, leading to jaw pain, difficulty in jaw movement, and other associated symptoms.Â
Acetaminophen, or paracetamol, is an over-the-counter pain reliever used to manage pain associated with temporomandibular disorders (TMD). TMD refers to conditions affecting the temporomandibular joint (TMJ) and the surrounding muscles, causing pain, jaw dysfunction, and other related symptoms.Â
Acetaminophen works by blocking pain signals in the brain and reducing fever. It is not classified as a nonsteroidal anti-inflammatory drug (NSAID) like ibuprofen or diclofenac, as it does not have significant anti-inflammatory effects.Â
Skeletal muscle relaxants are a class of medications that may be prescribed to manage the symptoms of temporomandibular disorders (TMD). These medications target the muscles involved in jaw movement, helping to reduce muscle tension, spasm, and associated pain.Â
5-10 mg orally once at nightÂ
Cyclobenzaprine is a muscle relaxant sometimes prescribed to manage muscle-related pain and muscle spasms associated with temporomandibular disorders (TMD).Â
Cyclobenzaprine acts on the central nervous system to help relax muscles and relieve muscle spasms. It increases the brain’s and spinal cord’s inhibitory signals, thereby reducing muscle contractions and promoting muscle relaxation.Â
400-800 mg orally three times daily.
Metaxalone is a muscle relaxant sometimes prescribed to manage muscle-related pain and muscle spasms associated with temporomandibular disorders (TMD).Â
Metaxalone acts on the central nervous system to help relax muscles and relieve muscle spasms. It works by inhibiting nerve impulses or altering the perception of pain signals in the brain and spinal cord.Â
Tricyclic antidepressantsÂ
Tricyclic antidepressants (TCAs) are a class of medications primarily used to treat depression. However, they can also be prescribed for other conditions, including some types of chronic pain, such as temporomandibular disorders (TMD). TMD refers to conditions affecting the jaw joint and surrounding muscles, causing pain and dysfunction.Â
Nortriptyline is a tricyclic antidepressant sometimes prescribed off-label to manage chronic pain, including pain associated with temporomandibular disorders (TMD). TMD refers to conditions affecting the temporomandibular joint (TMJ) and the surrounding muscles, leading to jaw pain, limited jaw movement, and other related symptoms.Â
Amitriptyline is a tricyclic antidepressant sometimes prescribed off-label to manage chronic pain, including pain associated with temporomandibular disorders (TMD). TMD refers to conditions affecting the temporomandibular joint (TMJ) and the muscles surrounding it, causing jaw pain, limited jaw movement, and other related symptoms.Â
Â
When conservative treatments such as medication, physical therapy, and lifestyle modifications do not provide sufficient relief for temporomandibular disorders (TMD), intervention with a procedure may be considered.
The choice of procedure depends on the specific TMD diagnosis, severity of symptoms, and individual patient factors. Here are a few examples of procedures that may be used for TMD:Â
Managing temporomandibular disorders typically involves several phases, each with specific goals and interventions. They include:Â
Temporomandibular Disorders (TMD) refer to conditions that affect the temporomandibular joint (TMJ), which connects the jawbone to the skull. TMD encompasses a range of disorders that cause pain and dysfunction in the joint of the jaw and the muscles that control jaw movement. It is estimated that around 5-12% of the population experiences TMD symptoms at some point, with a higher prevalence among women.Â
Temporomandibular Disorders (TMD) epidemiology provides insights into this condition’s prevalence, incidence, and distribution within populations. However, it’s important to note that epidemiological data on TMD can vary due to differences in study methodologies, diagnostic criteria, and population characteristics. Here is an overview of the epidemiological aspects of TMD:Â
The prevalence of TMD varies widely across different studies and populations. Estimates suggest that approximately 5-12% of the general population experiences TMD symptoms at some point. Women are more commonly affected by TMD, with a female-to-male ratio of around 2:1 to 9:1, depending on the study population.Â
Temporomandibular Disorders (TMD) pathophysiology involves complex interactions between various factors, including the temporomandibular joint (TMJ), associated muscles, nerves, and surrounding structures.Â
The etiology, or underlying causes, of Temporomandibular Disorders (TMD), is likely to arise from genetic, anatomical, biomechanical, behavioral, and environmental factors. While the exact cause can vary from person to person, the following are some commonly recognized etiological factors associated with TMD:Â
Prognostic factors in Temporomandibular Disorders (TMD) refer to the factors that can influence the course, outcome, and response to treatment for individuals with TMD. Understanding these prognostic factors can help clinicians predict the likely outcome of TMD and tailor treatment plans accordingly. While individual responses can vary, here are some commonly recognized prognostic factors in TMD:Â
Non-specific signs & symptomsÂ
   Systemic signs & symptomsÂ
Age Group:Â Â
Acute TMD is the sudden onset of symptoms after a specific event or trigger. For example, acute TMD may result from trauma to the jaw, such as a direct blow or whiplash injury. Acute presentations may involve severe pain, limited jaw movement, muscle spasms, and swelling in the jaw joint area.
Subacute TMD refers to symptoms that have been present for a relatively short duration, typically between acute and chronic presentations. The symptoms may have developed over days to weeks, including jaw pain, muscle stiffness, clicking or popping sounds, and mild limitations in jaw movement.
Temporomandibular Disorders (TMD) treatment aims to alleviate pain, improve jaw function, and enhance the overall quality of life. The specific treatment approach for TMD can vary depending on the individual’s symptoms, underlying causes, and the severity of the condition. It often involves a combination of conservative, non-invasive measures.Â
Modifying the environment can be a supportive strategy in treating temporomandibular disorders (TMD). By making certain adjustments, individuals with TMD can create a more favorable environment for their jaw and reduce potential triggers for pain and discomfort. Here are some modifications that can be helpful:Â
Patient education and self-care strategies can significantly contribute to TMD management. By empowering patients to take an active role in their care and providing them with the necessary tools and knowledge, they can better understand their condition, manage symptoms, and improve their quality of life.Â
Nonsteroidal anti-inflammatory drugs (NSAIDs) manage pain and inflammation associated with temporomandibular disorders (TMD) in adults. NSAIDs reduce the production of prostaglandins, which are responsible for pain and inflammation.Â
Diclofenac is an NSAID commonly used to relieve pain and reduce inflammation in various conditions, including temporomandibular disorders (TMD). TMD refers to conditions that affect the temporomandibular joint (TMJ) and the muscles surrounding it, leading to jaw pain, difficulty in jaw movement, and other associated symptoms.Â
Acetaminophen, or paracetamol, is an over-the-counter pain reliever used to manage pain associated with temporomandibular disorders (TMD). TMD refers to conditions affecting the temporomandibular joint (TMJ) and the surrounding muscles, causing pain, jaw dysfunction, and other related symptoms.Â
Acetaminophen works by blocking pain signals in the brain and reducing fever. It is not classified as a nonsteroidal anti-inflammatory drug (NSAID) like ibuprofen or diclofenac, as it does not have significant anti-inflammatory effects.Â
Skeletal muscle relaxants are a class of medications that may be prescribed to manage the symptoms of temporomandibular disorders (TMD). These medications target the muscles involved in jaw movement, helping to reduce muscle tension, spasm, and associated pain.Â
5-10 mg orally once at nightÂ
Cyclobenzaprine is a muscle relaxant sometimes prescribed to manage muscle-related pain and muscle spasms associated with temporomandibular disorders (TMD).Â
Cyclobenzaprine acts on the central nervous system to help relax muscles and relieve muscle spasms. It increases the brain’s and spinal cord’s inhibitory signals, thereby reducing muscle contractions and promoting muscle relaxation.Â
400-800 mg orally three times daily.
Metaxalone is a muscle relaxant sometimes prescribed to manage muscle-related pain and muscle spasms associated with temporomandibular disorders (TMD).Â
Metaxalone acts on the central nervous system to help relax muscles and relieve muscle spasms. It works by inhibiting nerve impulses or altering the perception of pain signals in the brain and spinal cord.Â
Tricyclic antidepressantsÂ
Tricyclic antidepressants (TCAs) are a class of medications primarily used to treat depression. However, they can also be prescribed for other conditions, including some types of chronic pain, such as temporomandibular disorders (TMD). TMD refers to conditions affecting the jaw joint and surrounding muscles, causing pain and dysfunction.Â
Nortriptyline is a tricyclic antidepressant sometimes prescribed off-label to manage chronic pain, including pain associated with temporomandibular disorders (TMD). TMD refers to conditions affecting the temporomandibular joint (TMJ) and the surrounding muscles, leading to jaw pain, limited jaw movement, and other related symptoms.Â
Amitriptyline is a tricyclic antidepressant sometimes prescribed off-label to manage chronic pain, including pain associated with temporomandibular disorders (TMD). TMD refers to conditions affecting the temporomandibular joint (TMJ) and the muscles surrounding it, causing jaw pain, limited jaw movement, and other related symptoms.Â
Â
When conservative treatments such as medication, physical therapy, and lifestyle modifications do not provide sufficient relief for temporomandibular disorders (TMD), intervention with a procedure may be considered.
The choice of procedure depends on the specific TMD diagnosis, severity of symptoms, and individual patient factors. Here are a few examples of procedures that may be used for TMD:Â
Managing temporomandibular disorders typically involves several phases, each with specific goals and interventions. They include:Â

Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.

On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.

When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
